TRPM3
protein-codingtransient receptor potential cation channel subfamily M member 3, the group of MicroRNA protein coding host genes|Transient receptor potential cation channels
Gene summary
The product of this gene belongs to the family of transient receptor potential (TRP) channels. TRP channels are cation-selective channels important for cellular calcium signaling and homeostasis. The protein encoded by this gene mediates calcium entry, and this entry is potentiated by calcium store depletion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~917.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015802
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0005090
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0005090
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0001071
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859365
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0015567
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0800439
Submitter: ClinGen
*TRPM3* was first reported in relation to autosomal dominant intellectual disability and epilepsy in 2019 (Dyment et al., PMID: 31278393). Phenotypic features include congenital hypotonia, global developmental delays, variable intellectual disability, ophthalmologic findings including strabismus and nystagmus, musculoskeletal findings including hip dysplasia, scoliosis, and club foot, variable seizure and epilepsy classifications, MRI abnormalities, and distinctive dysmorphic features. This curation includes 12 heterozygous missense variants reported in 12 probands with phenotypic similarity (PMIDs: 31278393, 34074259, 36648066, 37684057). Of these 12 heterozygous missense variants, 9 have functional data to support a gain of function effect. All distinct variants available in the literature are scored. Additional probands are reported in the literature, but all harbor variants already included in the curation. As the maximum score for genetic evidence (12 points) has already been reached, those individuals were not included in this curation. In summary, there is definitive evidence supporting the relationship between *TRPM3* and autosomal dominant syndromic complex neurodevelopmental disorder. This has been repeatedly demonstrated in the clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date May 23, 2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0859365
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859382
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859365
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859382
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0859382
Submitter: ClinGen
TRPM3 encodes a protein, transient receptor potential cation channel subfamily M member 3, which is temperature- and neurosteroid-sensitive. The first study by Bennett et al in 2014 (PMID: 25090642). reported TRPM3 in relationship to autosomal dominant cataract with or without high pressure glaucoma in a 5-generation Caucasian-American pedigree. Genome-wide linkage analysis mapped the cataract locus to the pericentric region of human chromosome 9, and exome sequencing of the linked region identified a heterozygous substitution of isoleucine-to-methionine at codon 65 (c.195A>G, p.Ile65Met) in TRPM3 transcript NM_001007471.2. This variant segregated fully with the cataract in the family. Functional studies of the human p.Ile65M knock-in mice model showed that heterozygous Trpm3-mutant mice developed cataract (2021, PMID: 33484482) and lens from the Trpm3-mutation mice displayed elevated cytosolic Ca2+ levels and an imbalance of sodium (Na+) and potassium (K+) ions, coupled with increased water content, suggesting failure of Trpm3-mutant lens to osmoregulation and gain-of-function as the disease mechanism (2024, PMID: 38334649). The second study by Li et al in 2018 (PMID: 29914532) sequenced 80 cataract-associated genes for a cohort of 39 Chinese pediatric cataract cases and detected a heterozygous variant, c.3920G>C, p.Arg1307Thr in TRPM3 transcript NM_206944.4, in one family. This variant segregated with the cataract in the family. No data of functional study is available for this variant. As of this curation, only two above-mentioned variants in TRPM3 have been linked to inherited form of cataract in two families. As of the genetic evidence, the case level and segregation data were scored up to 3.6 points. The functional experimental data from the human p.Ile65Met knock-in mouse model was scored up to 3.25 points. Taking together 6.85 points is scored in total with moderate evidence to support the TRPM3-cataract relationship. While more evidence is needed to establish this relationship definitively, no contradictory evidence has merged. This classification was approved by the ClinGen Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0859365
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Ophthalmologic
Rationale: The condition can include risk of glaucoma, and awareness may allow surveillance and early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRPM3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001366145.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 44 | 5 | 53 | ||
| missense | 10 | 381 | 26 | 3 | 420 | |
| nonsense | 8 | 8 | ||||
| start loss | 0 | |||||
| frameshift | 4 | 4 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 7 | 8 | |||
| Total | 0 | 11 | 404 | 70 | 8 | 493 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001353074.1 | 26 | MANE Select | |
| Ensembl | ENSP00000503830.2 | 26 | MANE Select | |
| RefSeq | NP_001007471.1 | 6 | Standard | |
| RefSeq | NP_001007472.2 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Stimuli-sensing channels
- Ion channel transport
- Transport of small molecules
- TRP channels
Biological Process
- cation transport
- detection of temperature stimulus
- sensory perception of temperature stimulus
- protein tetramerization
- calcium ion transmembrane transport
Molecular Function
- calcium activated cation channel activity
- cation channel activity
- calcium channel activity
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000377110
- Coding exons
- 25
- Length
- 917842
- Individuals with no LoFs
- 125670
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125748
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.18 | 716 | 998 | 0.717 | 0.0000576 | 11294 |
| Missense (PolyPhen) | 289 | 471.78 | 0.61257 | 5303 | ||
| Synonymous | 0.133 | 374 | 377 | 0.991 | 0.0000230 | 3243 |
| Loss of Function | 5.64 | 27 | 82.2 | 0.329 | 0.00000471 | 917 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00071 | 0.00069 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00033 | 0.00033 | rare |
| South Asian | 0.00037 | 0.00036 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium channel mediating constitutive calcium ion entry. Its activity is increased by reduction in extracellular osmolarity, by store depletion and muscarinic receptor activation. {ECO:0000269|PubMed:12672799, ECO:0000269|PubMed:12672827}.;
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- LoFtool
- 0.767
- RVIS EVS
- -1.09
- RVIS percentile EVS
- 6.98
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0628
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |